CAPITOL COUNSEL LLC

Lobbying for BOEHRINGER INGELHEIM ANIMAL HEALTH US · Animal health.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Georgia · Senate · $50,000.00 income · posted Oct 16, 2025

Lobbying activity 2

Animals

Issues regarding FDA animal drug approval process.

Medical/Disease Research/Clinical Labs

Issues regarding FDA animal drug approval process.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.